VAERS Reports NJ75B

VAERS 2657690

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NJ75B

mild

Staat: MO
Alter: 76,0
Geschlecht: F
Eingang: 18.07.2023
Impfdatum: 15.07.2023
Beginn: 16.07.2023
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site warmth

Symptomtext

Pt reported an irregular roundish red, warm area at injec

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: Pt saw Nurse at MD office
Aktuelle Erkrankungen: none known
Vorgeschichte: -
Andere Medikamente: Tylenol, Pregabalin
Allergien: none known
Vorherige Impfungen: -

VAERS 2693794

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NJ75B

gering

Staat: AZ
Alter: 69,0
Geschlecht: F
Eingang: 10.10.2023
Impfdatum: 03.10.2023
Beginn: 03.10.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Product preparation error

Symptomtext

received only diluent component of Shingrix, without the powder; received only diluent component of Shingrix, without the powder; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number NJ75B, expiry date 21-AUG-2024) for prophylaxis. On 03-OCT-2023, the patient received Shingrix. On 03-OCT-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received only diluent component of Shingrix, without the powder) and inappropriate dose of vaccine administered (Verbatim: received only diluent component of Shingrix, without the powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK receipt date: 3-Oct-2023 The case was received from the medical assistant. The reporter consented to follow-up via email. The patient only received diluent component of shingrix without powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -